Global Pharmaceutical CDMO and Contract Manufacturing Services Market Growth (Status and Outlook) 2026-2032
The global Pharmaceutical CDMO and Contract Manufacturing Services market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
In order to reduce drug R&D costs and improve production efficiency, pharmaceutical company customers entrust pharmaceutical process R&D and production to customized companies. The company accepts the entrustment of multinational pharmaceutical companies to provide pharmaceutical process research and development and drug production services, which are CDMO services.
United States market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pharmaceutical CDMO and Contract Manufacturing Services players cover Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Pharmaceutical CDMO and Contract Manufacturing Services Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO and Contract Manufacturing Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO and Contract Manufacturing Services sales for 2026 through 2032. With Pharmaceutical CDMO and Contract Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO and Contract Manufacturing Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO and Contract Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical CDMO and Contract Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO and Contract Manufacturing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO and Contract Manufacturing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO and Contract Manufacturing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO and Contract Manufacturing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
In order to reduce drug R&D costs and improve production efficiency, pharmaceutical company customers entrust pharmaceutical process R&D and production to customized companies. The company accepts the entrustment of multinational pharmaceutical companies to provide pharmaceutical process research and development and drug production services, which are CDMO services.
United States market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Pharmaceutical CDMO and Contract Manufacturing Services players cover Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Pharmaceutical CDMO and Contract Manufacturing Services Industry Forecast” looks at past sales and reviews total world Pharmaceutical CDMO and Contract Manufacturing Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Pharmaceutical CDMO and Contract Manufacturing Services sales for 2026 through 2032. With Pharmaceutical CDMO and Contract Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical CDMO and Contract Manufacturing Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical CDMO and Contract Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical CDMO and Contract Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical CDMO and Contract Manufacturing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical CDMO and Contract Manufacturing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical CDMO and Contract Manufacturing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical CDMO and Contract Manufacturing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Drug Development
- API production
- Pharma Industry
- Biotechnology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Haixiang Pharmaceutical
- Innovent Biologics
- Betta Pharmaceuticals
- Jiuzhou Pharmaceutical
- Puluo Pharmaceutical
- Menohua
- Tianyu shares
- Aoxiang Pharmaceutical
- Hetero
- CellMark
- R&D Systems
- Porton Pharmaceuticals
- Kai Laiying
- Smart Life
- Notai Biotech
- Aurobindo Pharma
- Lonza Group
- Catalent Inc.
- Recipharm AB
- Jubilant Pharmova Ltd
- Patheon Inc. (Thermo Fisher Scientific Inc.)
- Boehringer Ingelheim Group
- Pfizer CentreSource
- Baxter International Inc.
- Lonza Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2021-2032)
2.1.2 Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Pharmaceutical CDMO and Contract Manufacturing Services by Country/Region (2021, 2025 & 2032)
2.2 Pharmaceutical CDMO and Contract Manufacturing Services Segment by Type
2.2.1 Drug Development
2.2.2 API production
2.2.3 Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type
2.2.3.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
2.3 Pharmaceutical CDMO and Contract Manufacturing Services Segment by Application
2.3.1 Pharma Industry
2.3.2 Biotechnology
2.3.3 Others
2.3.4 Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application
2.3.4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
3 PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Player
3.1.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2021-2026)
3.1.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Player (2021-2026)
3.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES BY REGION
4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026)
4.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
4.4 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
4.5 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026)
5.2 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
5.3 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026)
6.2 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
6.3 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026)
7.2 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
7.3 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services by Region (2021-2026)
8.2 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES MARKET FORECAST
10.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.1.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.1.2 Americas Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.1.3 APAC Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.1.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2 Americas Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Country (2027-2032)
10.2.1 United States Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2.2 Canada Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2.3 Mexico Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2.4 Brazil Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3 APAC Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.3.1 China Pharmaceutical CDMO and Contract Manufacturing Services Market Forecast
10.3.2 Japan Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.3 Korea Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.4 Southeast Asia Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.5 India Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.6 Australia Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Country (2027-2032)
10.4.1 Germany Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.2 France Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.3 UK Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.4 Italy Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.5 Russia Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5.2 South Africa Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5.3 Israel Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5.4 Turkey Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.6 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Type (2027-2032)
10.7 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Haixiang Pharmaceutical
11.1.1 Haixiang Pharmaceutical Company Information
11.1.2 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.1.3 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Haixiang Pharmaceutical Main Business Overview
11.1.5 Haixiang Pharmaceutical Latest Developments
11.2 Innovent Biologics
11.2.1 Innovent Biologics Company Information
11.2.2 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.2.3 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Innovent Biologics Main Business Overview
11.2.5 Innovent Biologics Latest Developments
11.3 Betta Pharmaceuticals
11.3.1 Betta Pharmaceuticals Company Information
11.3.2 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.3.3 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Betta Pharmaceuticals Main Business Overview
11.3.5 Betta Pharmaceuticals Latest Developments
11.4 Jiuzhou Pharmaceutical
11.4.1 Jiuzhou Pharmaceutical Company Information
11.4.2 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.4.3 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Jiuzhou Pharmaceutical Main Business Overview
11.4.5 Jiuzhou Pharmaceutical Latest Developments
11.5 Puluo Pharmaceutical
11.5.1 Puluo Pharmaceutical Company Information
11.5.2 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.5.3 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Puluo Pharmaceutical Main Business Overview
11.5.5 Puluo Pharmaceutical Latest Developments
11.6 Menohua
11.6.1 Menohua Company Information
11.6.2 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.6.3 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Menohua Main Business Overview
11.6.5 Menohua Latest Developments
11.7 Tianyu shares
11.7.1 Tianyu shares Company Information
11.7.2 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.7.3 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Tianyu shares Main Business Overview
11.7.5 Tianyu shares Latest Developments
11.8 Aoxiang Pharmaceutical
11.8.1 Aoxiang Pharmaceutical Company Information
11.8.2 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.8.3 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Aoxiang Pharmaceutical Main Business Overview
11.8.5 Aoxiang Pharmaceutical Latest Developments
11.9 Hetero
11.9.1 Hetero Company Information
11.9.2 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.9.3 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Hetero Main Business Overview
11.9.5 Hetero Latest Developments
11.10 CellMark
11.10.1 CellMark Company Information
11.10.2 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.10.3 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CellMark Main Business Overview
11.10.5 CellMark Latest Developments
11.11 R&D Systems
11.11.1 R&D Systems Company Information
11.11.2 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.11.3 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 R&D Systems Main Business Overview
11.11.5 R&D Systems Latest Developments
11.12 Porton Pharmaceuticals
11.12.1 Porton Pharmaceuticals Company Information
11.12.2 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.12.3 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Porton Pharmaceuticals Main Business Overview
11.12.5 Porton Pharmaceuticals Latest Developments
11.13 Kai Laiying
11.13.1 Kai Laiying Company Information
11.13.2 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.13.3 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kai Laiying Main Business Overview
11.13.5 Kai Laiying Latest Developments
11.14 Smart Life
11.14.1 Smart Life Company Information
11.14.2 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.14.3 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Smart Life Main Business Overview
11.14.5 Smart Life Latest Developments
11.15 Notai Biotech
11.15.1 Notai Biotech Company Information
11.15.2 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.15.3 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Notai Biotech Main Business Overview
11.15.5 Notai Biotech Latest Developments
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Information
11.16.2 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.16.3 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Aurobindo Pharma Main Business Overview
11.16.5 Aurobindo Pharma Latest Developments
11.17 Lonza Group
11.17.1 Lonza Group Company Information
11.17.2 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.17.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Lonza Group Main Business Overview
11.17.5 Lonza Group Latest Developments
11.18 Catalent Inc.
11.18.1 Catalent Inc. Company Information
11.18.2 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.18.3 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Catalent Inc. Main Business Overview
11.18.5 Catalent Inc. Latest Developments
11.19 Recipharm AB
11.19.1 Recipharm AB Company Information
11.19.2 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.19.3 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Recipharm AB Main Business Overview
11.19.5 Recipharm AB Latest Developments
11.20 Jubilant Pharmova Ltd
11.20.1 Jubilant Pharmova Ltd Company Information
11.20.2 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.20.3 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Jubilant Pharmova Ltd Main Business Overview
11.20.5 Jubilant Pharmova Ltd Latest Developments
11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Information
11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Main Business Overview
11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Latest Developments
11.22 Boehringer Ingelheim Group
11.22.1 Boehringer Ingelheim Group Company Information
11.22.2 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.22.3 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Boehringer Ingelheim Group Main Business Overview
11.22.5 Boehringer Ingelheim Group Latest Developments
11.23 Pfizer CentreSource
11.23.1 Pfizer CentreSource Company Information
11.23.2 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.23.3 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Pfizer CentreSource Main Business Overview
11.23.5 Pfizer CentreSource Latest Developments
11.24 Baxter International Inc.
11.24.1 Baxter International Inc. Company Information
11.24.2 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.24.3 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Baxter International Inc. Main Business Overview
11.24.5 Baxter International Inc. Latest Developments
11.25 Lonza Group
11.25.1 Lonza Group Company Information
11.25.2 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.25.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Lonza Group Main Business Overview
11.25.5 Lonza Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2021-2032)
2.1.2 Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Pharmaceutical CDMO and Contract Manufacturing Services by Country/Region (2021, 2025 & 2032)
2.2 Pharmaceutical CDMO and Contract Manufacturing Services Segment by Type
2.2.1 Drug Development
2.2.2 API production
2.2.3 Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type
2.2.3.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
2.3 Pharmaceutical CDMO and Contract Manufacturing Services Segment by Application
2.3.1 Pharma Industry
2.3.2 Biotechnology
2.3.3 Others
2.3.4 Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application
2.3.4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
3 PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Player
3.1.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2021-2026)
3.1.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Player (2021-2026)
3.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES BY REGION
4.1 Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026)
4.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Annual Revenue by Country/Region (2021-2026)
4.3 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
4.4 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
4.5 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
4.6 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026)
5.2 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
5.3 Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026)
6.2 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
6.3 APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026)
7.2 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
7.3 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services by Region (2021-2026)
8.2 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026)
8.3 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO AND CONTRACT MANUFACTURING SERVICES MARKET FORECAST
10.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.1.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.1.2 Americas Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.1.3 APAC Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.1.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2 Americas Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Country (2027-2032)
10.2.1 United States Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2.2 Canada Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2.3 Mexico Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.2.4 Brazil Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3 APAC Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.3.1 China Pharmaceutical CDMO and Contract Manufacturing Services Market Forecast
10.3.2 Japan Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.3 Korea Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.4 Southeast Asia Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.5 India Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.3.6 Australia Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Country (2027-2032)
10.4.1 Germany Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.2 France Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.3 UK Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.4 Italy Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.4.5 Russia Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Region (2027-2032)
10.5.1 Egypt Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5.2 South Africa Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5.3 Israel Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.5.4 Turkey Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
10.6 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Type (2027-2032)
10.7 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Pharmaceutical CDMO and Contract Manufacturing Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 Haixiang Pharmaceutical
11.1.1 Haixiang Pharmaceutical Company Information
11.1.2 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.1.3 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Haixiang Pharmaceutical Main Business Overview
11.1.5 Haixiang Pharmaceutical Latest Developments
11.2 Innovent Biologics
11.2.1 Innovent Biologics Company Information
11.2.2 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.2.3 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Innovent Biologics Main Business Overview
11.2.5 Innovent Biologics Latest Developments
11.3 Betta Pharmaceuticals
11.3.1 Betta Pharmaceuticals Company Information
11.3.2 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.3.3 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Betta Pharmaceuticals Main Business Overview
11.3.5 Betta Pharmaceuticals Latest Developments
11.4 Jiuzhou Pharmaceutical
11.4.1 Jiuzhou Pharmaceutical Company Information
11.4.2 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.4.3 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Jiuzhou Pharmaceutical Main Business Overview
11.4.5 Jiuzhou Pharmaceutical Latest Developments
11.5 Puluo Pharmaceutical
11.5.1 Puluo Pharmaceutical Company Information
11.5.2 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.5.3 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Puluo Pharmaceutical Main Business Overview
11.5.5 Puluo Pharmaceutical Latest Developments
11.6 Menohua
11.6.1 Menohua Company Information
11.6.2 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.6.3 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Menohua Main Business Overview
11.6.5 Menohua Latest Developments
11.7 Tianyu shares
11.7.1 Tianyu shares Company Information
11.7.2 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.7.3 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Tianyu shares Main Business Overview
11.7.5 Tianyu shares Latest Developments
11.8 Aoxiang Pharmaceutical
11.8.1 Aoxiang Pharmaceutical Company Information
11.8.2 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.8.3 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Aoxiang Pharmaceutical Main Business Overview
11.8.5 Aoxiang Pharmaceutical Latest Developments
11.9 Hetero
11.9.1 Hetero Company Information
11.9.2 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.9.3 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Hetero Main Business Overview
11.9.5 Hetero Latest Developments
11.10 CellMark
11.10.1 CellMark Company Information
11.10.2 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.10.3 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CellMark Main Business Overview
11.10.5 CellMark Latest Developments
11.11 R&D Systems
11.11.1 R&D Systems Company Information
11.11.2 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.11.3 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 R&D Systems Main Business Overview
11.11.5 R&D Systems Latest Developments
11.12 Porton Pharmaceuticals
11.12.1 Porton Pharmaceuticals Company Information
11.12.2 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.12.3 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Porton Pharmaceuticals Main Business Overview
11.12.5 Porton Pharmaceuticals Latest Developments
11.13 Kai Laiying
11.13.1 Kai Laiying Company Information
11.13.2 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.13.3 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kai Laiying Main Business Overview
11.13.5 Kai Laiying Latest Developments
11.14 Smart Life
11.14.1 Smart Life Company Information
11.14.2 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.14.3 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Smart Life Main Business Overview
11.14.5 Smart Life Latest Developments
11.15 Notai Biotech
11.15.1 Notai Biotech Company Information
11.15.2 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.15.3 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Notai Biotech Main Business Overview
11.15.5 Notai Biotech Latest Developments
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Information
11.16.2 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.16.3 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Aurobindo Pharma Main Business Overview
11.16.5 Aurobindo Pharma Latest Developments
11.17 Lonza Group
11.17.1 Lonza Group Company Information
11.17.2 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.17.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Lonza Group Main Business Overview
11.17.5 Lonza Group Latest Developments
11.18 Catalent Inc.
11.18.1 Catalent Inc. Company Information
11.18.2 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.18.3 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Catalent Inc. Main Business Overview
11.18.5 Catalent Inc. Latest Developments
11.19 Recipharm AB
11.19.1 Recipharm AB Company Information
11.19.2 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.19.3 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Recipharm AB Main Business Overview
11.19.5 Recipharm AB Latest Developments
11.20 Jubilant Pharmova Ltd
11.20.1 Jubilant Pharmova Ltd Company Information
11.20.2 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.20.3 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Jubilant Pharmova Ltd Main Business Overview
11.20.5 Jubilant Pharmova Ltd Latest Developments
11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Information
11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Main Business Overview
11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Latest Developments
11.22 Boehringer Ingelheim Group
11.22.1 Boehringer Ingelheim Group Company Information
11.22.2 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.22.3 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Boehringer Ingelheim Group Main Business Overview
11.22.5 Boehringer Ingelheim Group Latest Developments
11.23 Pfizer CentreSource
11.23.1 Pfizer CentreSource Company Information
11.23.2 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.23.3 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Pfizer CentreSource Main Business Overview
11.23.5 Pfizer CentreSource Latest Developments
11.24 Baxter International Inc.
11.24.1 Baxter International Inc. Company Information
11.24.2 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.24.3 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Baxter International Inc. Main Business Overview
11.24.5 Baxter International Inc. Latest Developments
11.25 Lonza Group
11.25.1 Lonza Group Company Information
11.25.2 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
11.25.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Lonza Group Main Business Overview
11.25.5 Lonza Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pharmaceutical CDMO and Contract Manufacturing Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Drug Development
Table 4. Major Players of API production
Table 5. Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Table 8. Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Table 11. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Player (2021-2026)
Table 13. Pharmaceutical CDMO and Contract Manufacturing Services Key Players Head office and Products Offered
Table 14. Pharmaceutical CDMO and Contract Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Table 19. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Country (2021-2026)
Table 23. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Table 25. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Table 27. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Table 29. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Country (2021-2026)
Table 33. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO and Contract Manufacturing Services
Table 39. Key Market Challenges & Risks of Pharmaceutical CDMO and Contract Manufacturing Services
Table 40. Key Industry Trends of Pharmaceutical CDMO and Contract Manufacturing Services
Table 41. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Haixiang Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 46. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 47. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Haixiang Pharmaceutical Main Business
Table 49. Haixiang Pharmaceutical Latest Developments
Table 50. Innovent Biologics Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 51. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 52. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Innovent Biologics Main Business
Table 54. Innovent Biologics Latest Developments
Table 55. Betta Pharmaceuticals Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 56. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 57. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Betta Pharmaceuticals Main Business
Table 59. Betta Pharmaceuticals Latest Developments
Table 60. Jiuzhou Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 61. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 62. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Jiuzhou Pharmaceutical Main Business
Table 64. Jiuzhou Pharmaceutical Latest Developments
Table 65. Puluo Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 66. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 67. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Puluo Pharmaceutical Main Business
Table 69. Puluo Pharmaceutical Latest Developments
Table 70. Menohua Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 71. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 72. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Menohua Main Business
Table 74. Menohua Latest Developments
Table 75. Tianyu shares Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 76. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 77. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Tianyu shares Main Business
Table 79. Tianyu shares Latest Developments
Table 80. Aoxiang Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 81. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 82. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Aoxiang Pharmaceutical Main Business
Table 84. Aoxiang Pharmaceutical Latest Developments
Table 85. Hetero Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 86. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 87. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Hetero Main Business
Table 89. Hetero Latest Developments
Table 90. CellMark Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 91. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 92. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CellMark Main Business
Table 94. CellMark Latest Developments
Table 95. R&D Systems Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 96. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 97. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. R&D Systems Main Business
Table 99. R&D Systems Latest Developments
Table 100. Porton Pharmaceuticals Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 101. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 102. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Porton Pharmaceuticals Main Business
Table 104. Porton Pharmaceuticals Latest Developments
Table 105. Kai Laiying Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 106. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 107. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Kai Laiying Main Business
Table 109. Kai Laiying Latest Developments
Table 110. Smart Life Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 111. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 112. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Smart Life Main Business
Table 114. Smart Life Latest Developments
Table 115. Notai Biotech Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 116. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 117. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Notai Biotech Main Business
Table 119. Notai Biotech Latest Developments
Table 120. Aurobindo Pharma Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 121. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 122. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Aurobindo Pharma Main Business
Table 124. Aurobindo Pharma Latest Developments
Table 125. Lonza Group Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 126. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 127. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Lonza Group Main Business
Table 129. Lonza Group Latest Developments
Table 130. Catalent Inc. Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 131. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 132. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Catalent Inc. Main Business
Table 134. Catalent Inc. Latest Developments
Table 135. Recipharm AB Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 136. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 137. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Recipharm AB Main Business
Table 139. Recipharm AB Latest Developments
Table 140. Jubilant Pharmova Ltd Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 141. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 142. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Jubilant Pharmova Ltd Main Business
Table 144. Jubilant Pharmova Ltd Latest Developments
Table 145. Patheon Inc. (Thermo Fisher Scientific Inc.) Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Main Business
Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Latest Developments
Table 150. Boehringer Ingelheim Group Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 151. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 152. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Boehringer Ingelheim Group Main Business
Table 154. Boehringer Ingelheim Group Latest Developments
Table 155. Pfizer CentreSource Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 156. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 157. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Pfizer CentreSource Main Business
Table 159. Pfizer CentreSource Latest Developments
Table 160. Baxter International Inc. Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 161. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 162. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Baxter International Inc. Main Business
Table 164. Baxter International Inc. Latest Developments
Table 165. Lonza Group Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 166. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 167. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. Lonza Group Main Business
Table 169. Lonza Group Latest Developments
Table 1. Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Pharmaceutical CDMO and Contract Manufacturing Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Drug Development
Table 4. Major Players of API production
Table 5. Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Table 8. Pharmaceutical CDMO and Contract Manufacturing Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Table 11. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Player (2021-2026)
Table 13. Pharmaceutical CDMO and Contract Manufacturing Services Key Players Head office and Products Offered
Table 14. Pharmaceutical CDMO and Contract Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Table 19. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Country (2021-2026)
Table 23. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Table 25. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Table 27. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Table 29. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Country (2021-2026)
Table 33. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO and Contract Manufacturing Services
Table 39. Key Market Challenges & Risks of Pharmaceutical CDMO and Contract Manufacturing Services
Table 40. Key Industry Trends of Pharmaceutical CDMO and Contract Manufacturing Services
Table 41. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Haixiang Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 46. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 47. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Haixiang Pharmaceutical Main Business
Table 49. Haixiang Pharmaceutical Latest Developments
Table 50. Innovent Biologics Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 51. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 52. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Innovent Biologics Main Business
Table 54. Innovent Biologics Latest Developments
Table 55. Betta Pharmaceuticals Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 56. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 57. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Betta Pharmaceuticals Main Business
Table 59. Betta Pharmaceuticals Latest Developments
Table 60. Jiuzhou Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 61. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 62. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Jiuzhou Pharmaceutical Main Business
Table 64. Jiuzhou Pharmaceutical Latest Developments
Table 65. Puluo Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 66. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 67. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Puluo Pharmaceutical Main Business
Table 69. Puluo Pharmaceutical Latest Developments
Table 70. Menohua Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 71. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 72. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Menohua Main Business
Table 74. Menohua Latest Developments
Table 75. Tianyu shares Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 76. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 77. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Tianyu shares Main Business
Table 79. Tianyu shares Latest Developments
Table 80. Aoxiang Pharmaceutical Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 81. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 82. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Aoxiang Pharmaceutical Main Business
Table 84. Aoxiang Pharmaceutical Latest Developments
Table 85. Hetero Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 86. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 87. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Hetero Main Business
Table 89. Hetero Latest Developments
Table 90. CellMark Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 91. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 92. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CellMark Main Business
Table 94. CellMark Latest Developments
Table 95. R&D Systems Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 96. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 97. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. R&D Systems Main Business
Table 99. R&D Systems Latest Developments
Table 100. Porton Pharmaceuticals Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 101. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 102. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Porton Pharmaceuticals Main Business
Table 104. Porton Pharmaceuticals Latest Developments
Table 105. Kai Laiying Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 106. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 107. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Kai Laiying Main Business
Table 109. Kai Laiying Latest Developments
Table 110. Smart Life Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 111. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 112. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Smart Life Main Business
Table 114. Smart Life Latest Developments
Table 115. Notai Biotech Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 116. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 117. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Notai Biotech Main Business
Table 119. Notai Biotech Latest Developments
Table 120. Aurobindo Pharma Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 121. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 122. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Aurobindo Pharma Main Business
Table 124. Aurobindo Pharma Latest Developments
Table 125. Lonza Group Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 126. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 127. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Lonza Group Main Business
Table 129. Lonza Group Latest Developments
Table 130. Catalent Inc. Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 131. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 132. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Catalent Inc. Main Business
Table 134. Catalent Inc. Latest Developments
Table 135. Recipharm AB Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 136. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 137. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Recipharm AB Main Business
Table 139. Recipharm AB Latest Developments
Table 140. Jubilant Pharmova Ltd Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 141. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 142. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Jubilant Pharmova Ltd Main Business
Table 144. Jubilant Pharmova Ltd Latest Developments
Table 145. Patheon Inc. (Thermo Fisher Scientific Inc.) Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Main Business
Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Latest Developments
Table 150. Boehringer Ingelheim Group Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 151. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 152. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Boehringer Ingelheim Group Main Business
Table 154. Boehringer Ingelheim Group Latest Developments
Table 155. Pfizer CentreSource Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 156. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 157. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Pfizer CentreSource Main Business
Table 159. Pfizer CentreSource Latest Developments
Table 160. Baxter International Inc. Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 161. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 162. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Baxter International Inc. Main Business
Table 164. Baxter International Inc. Latest Developments
Table 165. Lonza Group Details, Company Type, Pharmaceutical CDMO and Contract Manufacturing Services Area Served and Its Competitors
Table 166. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product Offered
Table 167. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. Lonza Group Main Business
Table 169. Lonza Group Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO and Contract Manufacturing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pharmaceutical CDMO and Contract Manufacturing Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pharmaceutical CDMO and Contract Manufacturing Services Sales Market Share by Country/Region (2025)
Figure 8. Pharmaceutical CDMO and Contract Manufacturing Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type in 2025
Figure 10. Pharmaceutical CDMO and Contract Manufacturing Services in Pharma Industry
Figure 11. Global Pharmaceutical CDMO and Contract Manufacturing Services Market: Pharma Industry (2021-2026) & ($ millions)
Figure 12. Pharmaceutical CDMO and Contract Manufacturing Services in Biotechnology
Figure 13. Global Pharmaceutical CDMO and Contract Manufacturing Services Market: Biotechnology (2021-2026) & ($ millions)
Figure 14. Pharmaceutical CDMO and Contract Manufacturing Services in Others
Figure 15. Global Pharmaceutical CDMO and Contract Manufacturing Services Market: Others (2021-2026) & ($ millions)
Figure 16. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application in 2025
Figure 17. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Player in 2025
Figure 18. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Pharmaceutical CDMO and Contract Manufacturing Services Value Market Share by Country in 2025
Figure 24. United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region in 2025
Figure 29. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Figure 31. China Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Country in 2025
Figure 38. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 57. United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 61. China Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 65. India Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 68. France Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 69. UK Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 76. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 1. Pharmaceutical CDMO and Contract Manufacturing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Pharmaceutical CDMO and Contract Manufacturing Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Pharmaceutical CDMO and Contract Manufacturing Services Sales Market Share by Country/Region (2025)
Figure 8. Pharmaceutical CDMO and Contract Manufacturing Services Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type in 2025
Figure 10. Pharmaceutical CDMO and Contract Manufacturing Services in Pharma Industry
Figure 11. Global Pharmaceutical CDMO and Contract Manufacturing Services Market: Pharma Industry (2021-2026) & ($ millions)
Figure 12. Pharmaceutical CDMO and Contract Manufacturing Services in Biotechnology
Figure 13. Global Pharmaceutical CDMO and Contract Manufacturing Services Market: Biotechnology (2021-2026) & ($ millions)
Figure 14. Pharmaceutical CDMO and Contract Manufacturing Services in Others
Figure 15. Global Pharmaceutical CDMO and Contract Manufacturing Services Market: Others (2021-2026) & ($ millions)
Figure 16. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application in 2025
Figure 17. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Player in 2025
Figure 18. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Figure 19. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 20. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 21. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2021-2026 ($ millions)
Figure 23. Americas Pharmaceutical CDMO and Contract Manufacturing Services Value Market Share by Country in 2025
Figure 24. United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region in 2025
Figure 29. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Figure 30. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Figure 31. China Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 35. India Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Country in 2025
Figure 38. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Figure 39. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Figure 40. Germany Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 41. France Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 54. APAC Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 55. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 57. United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 58. Canada Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 59. Mexico Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 60. Brazil Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 61. China Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 62. Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 63. Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 65. India Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 66. Australia Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 67. Germany Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 68. France Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 69. UK Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 70. Italy Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 71. Russia Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 72. Egypt Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 73. South Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 74. Israel Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 75. Turkey Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
Figure 76. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Pharmaceutical CDMO and Contract Manufacturing Services Market Size 2027-2032 ($ millions)
